Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis"

Antimicrob Agents Chemother. 2017 Aug 24;61(9):e01524-17. doi: 10.1128/AAC.01524-17. Print 2017 Sep.

C A Peloquin¹, G E Velásquez^{2

3}, L Lecca^{3

4}, R I Calderón⁴, J Coit², M Milstein², E Osso², J Jimenez⁴, K Tintaya⁴, E Sanchez Garavito⁵, D Vargas Vasquez⁶, C D Mitnick^{3

7}, G Davies⁸

¹ University of Florida College of Pharmacy and Emerging Pathogens Institute, Gainesville, Florida, USA.
² Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
³ Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
⁴ Socios En Salud, Lima, Peru.
⁵ Hospital Nacional Sergio Bernales, Lima, Peru.
⁶ Hospital Nacional Hipólito Unanue, Lima, Peru.
⁷ Partners In Health, Boston, Massachusetts, USA.
⁸ Institutes of Infection and Global Health and Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

No abstract available

Publication types